This content is from:Premium Elliott Versus Greenlight, Round Two Why Elliott is all in on the shares of Bayer, which Greenlight unloaded in the first quarter. ByStephen Taub June 27, 2019
This content is from:www.yabo88.com Bayer’s Monsanto Deal Highlights Genetic Engineering Opportunities German pharmaceuticals giant Bayer’s $66 billion acquisition of Monsanto is about more than just seeds. ByKaitlin Ugolik September 14, 2016
This content is from:Premium Jamie Dinan’s York Posts Best Results Since 2009 The multistrategy firm got a break last year, but it continues to suffer from redemptions. ByStephen Taub January 31, 2018
This content is from:365亚博 Daily Agenda: Fed Confirms June Hike on the Table Markets sell off on release of FOMC notes; Bayer makes Monsanto bid official; more corruption allegations for Malaysian fund; Wal-Mart beats estmates. ByAndrew Barber May 19, 2016
This content is from:365亚博 Daily Agenda: Greek Aid Approved EU and IMF agree to release funds, relieve Greek debt; Monsanto rejects Bayer offer but courtship continues; SEC probes Alibaba; PBOC lowers yuan peg; Tiffany results bad news for luxury market. ByAndrew Barber May 25, 2016
This content is from:365亚博 The Morning Brief: Paulson Takes Stake in Monsanto Target Syngenta ByAmanda Cantrell July 17, 2015
